WW International, Inc. (WW)
Price:
22.05 USD
( + 1.43 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
YY Group Holding Limited
VALUE SCORE:
8
2nd position
Mister Car Wash, Inc.
VALUE SCORE:
8
The best
Park Ha Biological Technology Co., Ltd. Ordinary Shares
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
WW International, Inc. provides weight management products and services worldwide. The company operates in four segments: North America, Continental Europe, United Kingdom, and Other. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and Web-based products, including personal coaching and digital products; and allows members to inspire and support each other by sharing their experiences with other people on weight management and wellness journeys. In addition, it offers various consumer products, including bars, snacks, cookbooks, kitchen tools, and other products. Further, the company licenses its trademarks and other intellectual property in food, beverages, and other relevant consumer products and services, as well as provides publishing services. It offers products through e-commerce platforms and through partners. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.
NEWS
Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era
globenewswire.com
2026-02-10 09:00:00The new partnership combines Weight Watchers' scientifically-backed medical and behavioral expertise with PVOLVE's clinically-studied method to support members at every age and stage of life The new partnership combines Weight Watchers' scientifically-backed medical and behavioral expertise with PVOLVE's clinically-studied method to support members at every age and stage of life
Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health
globenewswire.com
2026-01-05 08:05:00A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone
WW International (NASDAQ:WW) Share Price Passes Above 200-Day Moving Average – Here’s What Happened
defenseworld.net
2025-12-30 02:56:44WW International, Inc. (NASDAQ: WW - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $27.60 and traded as high as $29.40. WW International shares last traded at $28.44, with a volume of 251,911 shares changing hands. Analyst Upgrades and Downgrades WW has
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
globenewswire.com
2025-12-16 09:05:00A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
globenewswire.com
2025-12-16 09:05:00A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
globenewswire.com
2025-12-16 09:05:00A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
globenewswire.com
2025-12-16 08:55:00A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last
WW International: First Normal Quarter Shows Signs Of Stability
seekingalpha.com
2025-11-18 13:03:23WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cautious Q4 guidance, which may keep investors wary until trends improve. Key catalysts ahead include FDA decisions on GLP-1 compounding, expanded insurance coverage, and new partnerships with pharma and insurance providers.
WeightWatchers to sell Novo Nordisk's Wegovy pill after 2026 launch
reuters.com
2025-11-12 14:04:30WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordisk's much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker.
WW International, Inc. (WW) Q3 2025 Earnings Call Transcript
seekingalpha.com
2025-11-06 16:36:13WW International, Inc. ( WW ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants David Helderman - Director of Investor Relations Tara Comonte - President, CEO & Director Felicia DellaFortuna - Chief Financial Officer Jon Volkmann - Chief Operations Officer Conference Call Participants Alex Fuhrman - Lucid Capital Markets, LLC, Research Division Justin Ages - CJS Securities, Inc. Nathaniel Feather - Morgan Stanley, Research Division Presentation Operator Good morning, and welcome to WeightWatchers International's Third Quarter 2025 Results Conference Call. [Operator Instructions] Please note this event is being recorded.
WeightWatchers Announces Third Quarter 2025 Results
globenewswire.com
2025-11-06 07:00:00End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss of $58 million; Net Loss Margin of 33.4%; Adjusted EBITDA 1 of $43 million and Adjusted EBITDA Margin 1 of 24.9% Narrowing 2025 Guidance to the higher end of previous ranges for Revenue and Adjusted EBITDA1 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the third quarter of fiscal 2025 ended September 30, 2025 2 in this Earnings Press Release and a Shareholder Letter posted on the Company's Corporate Website . Third Quarter 2025 Overview Q3 reflected a significantly strengthened balance sheet as the Company's first full quarter post-restructuring, with total debt reduced by more than 70% (~$1.1 billion) and Cash at quarter end increasing to $170 million from $152 million at the end of Q2.
WeightWatchers International shares climb after partnership with Amazon Pharmacy
invezz.com
2025-10-21 11:00:02Shares of WW International rose nearly 6% in premarket trading on Monday after the company announced a new partnership with Amazon to deliver GLP-1 weight-loss drugs and other prescription medications directly to its members.
WeightWatchers to offer faster delivery of weight loss drugs through new partnership with Amazon Pharmacy
proactiveinvestors.com
2025-10-20 11:50:49Weight management company WW International, also known as WeightWatchers (NASDAQ:WW), has partnered with Amazon Pharmacy to streamline access to weight management medications for WeightWatchers Clinic members. Under the partnership, members can view real-time medication availability, compare delivery options, and receive prescriptions through Amazon Pharmacy.
WeightWatchers Collaborates With Amazon Pharmacy to Increase Medication Delivery Speed, Convenience and Savings For Members
globenewswire.com
2025-10-20 06:30:00NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced a collaboration with Amazon Pharmacy , a full-service online pharmacy. Through this collaboration, WeightWatchers Clinic members will gain access to real-time medication availability, automatic coupon savings, and fast, reliable home delivery for weight management medications.
WeightWatchers Launches RxFlexFund™, a New Employer Model for Expanding GLP-1 Coverage
globenewswire.com
2025-10-17 09:10:00Provides a Differentiated Cost-Sharing Framework for GLP-1 Medications Paired With Clinical Oversight and Proven Behavior Change Support from WeightWatchers Clinic Provides a Differentiated Cost-Sharing Framework for GLP-1 Medications Paired With Clinical Oversight and Proven Behavior Change Support from WeightWatchers Clinic
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
globenewswire.com
2025-10-15 11:05:00Members See 46% Improvement in Work-Related Quality of Life and 53% Improvement in Overall Quality of Life
Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era
globenewswire.com
2026-02-10 09:00:00The new partnership combines Weight Watchers' scientifically-backed medical and behavioral expertise with PVOLVE's clinically-studied method to support members at every age and stage of life The new partnership combines Weight Watchers' scientifically-backed medical and behavioral expertise with PVOLVE's clinically-studied method to support members at every age and stage of life
Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health
globenewswire.com
2026-01-05 08:05:00A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone
WW International (NASDAQ:WW) Share Price Passes Above 200-Day Moving Average – Here’s What Happened
defenseworld.net
2025-12-30 02:56:44WW International, Inc. (NASDAQ: WW - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $27.60 and traded as high as $29.40. WW International shares last traded at $28.44, with a volume of 251,911 shares changing hands. Analyst Upgrades and Downgrades WW has
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
globenewswire.com
2025-12-16 09:05:00A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
globenewswire.com
2025-12-16 09:05:00A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
globenewswire.com
2025-12-16 09:05:00A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
globenewswire.com
2025-12-16 08:55:00A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that last
WW International: First Normal Quarter Shows Signs Of Stability
seekingalpha.com
2025-11-18 13:03:23WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cautious Q4 guidance, which may keep investors wary until trends improve. Key catalysts ahead include FDA decisions on GLP-1 compounding, expanded insurance coverage, and new partnerships with pharma and insurance providers.
WeightWatchers to sell Novo Nordisk's Wegovy pill after 2026 launch
reuters.com
2025-11-12 14:04:30WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordisk's much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker.
WW International, Inc. (WW) Q3 2025 Earnings Call Transcript
seekingalpha.com
2025-11-06 16:36:13WW International, Inc. ( WW ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants David Helderman - Director of Investor Relations Tara Comonte - President, CEO & Director Felicia DellaFortuna - Chief Financial Officer Jon Volkmann - Chief Operations Officer Conference Call Participants Alex Fuhrman - Lucid Capital Markets, LLC, Research Division Justin Ages - CJS Securities, Inc. Nathaniel Feather - Morgan Stanley, Research Division Presentation Operator Good morning, and welcome to WeightWatchers International's Third Quarter 2025 Results Conference Call. [Operator Instructions] Please note this event is being recorded.
WeightWatchers Announces Third Quarter 2025 Results
globenewswire.com
2025-11-06 07:00:00End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss of $58 million; Net Loss Margin of 33.4%; Adjusted EBITDA 1 of $43 million and Adjusted EBITDA Margin 1 of 24.9% Narrowing 2025 Guidance to the higher end of previous ranges for Revenue and Adjusted EBITDA1 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced its results for the third quarter of fiscal 2025 ended September 30, 2025 2 in this Earnings Press Release and a Shareholder Letter posted on the Company's Corporate Website . Third Quarter 2025 Overview Q3 reflected a significantly strengthened balance sheet as the Company's first full quarter post-restructuring, with total debt reduced by more than 70% (~$1.1 billion) and Cash at quarter end increasing to $170 million from $152 million at the end of Q2.
WeightWatchers International shares climb after partnership with Amazon Pharmacy
invezz.com
2025-10-21 11:00:02Shares of WW International rose nearly 6% in premarket trading on Monday after the company announced a new partnership with Amazon to deliver GLP-1 weight-loss drugs and other prescription medications directly to its members.
WeightWatchers to offer faster delivery of weight loss drugs through new partnership with Amazon Pharmacy
proactiveinvestors.com
2025-10-20 11:50:49Weight management company WW International, also known as WeightWatchers (NASDAQ:WW), has partnered with Amazon Pharmacy to streamline access to weight management medications for WeightWatchers Clinic members. Under the partnership, members can view real-time medication availability, compare delivery options, and receive prescriptions through Amazon Pharmacy.
WeightWatchers Collaborates With Amazon Pharmacy to Increase Medication Delivery Speed, Convenience and Savings For Members
globenewswire.com
2025-10-20 06:30:00NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced a collaboration with Amazon Pharmacy , a full-service online pharmacy. Through this collaboration, WeightWatchers Clinic members will gain access to real-time medication availability, automatic coupon savings, and fast, reliable home delivery for weight management medications.
WeightWatchers Launches RxFlexFund™, a New Employer Model for Expanding GLP-1 Coverage
globenewswire.com
2025-10-17 09:10:00Provides a Differentiated Cost-Sharing Framework for GLP-1 Medications Paired With Clinical Oversight and Proven Behavior Change Support from WeightWatchers Clinic Provides a Differentiated Cost-Sharing Framework for GLP-1 Medications Paired With Clinical Oversight and Proven Behavior Change Support from WeightWatchers Clinic
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
globenewswire.com
2025-10-15 11:05:00Members See 46% Improvement in Work-Related Quality of Life and 53% Improvement in Overall Quality of Life